ISRCTN46536242已完成未知
Post-Operative Radiotherapy for Non-Small Cell Lung Cancer
Medical Research Council (MRC) (UK)0 个研究点目标入组 308 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 308
研究概览
简要总结
1996 results in: https://www.ncbi.nlm.nih.gov/pubmed/8761382 (added 15/11/2019)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Either sex, aged 75 years or less
- •2. World Health Organisation (WHO) performance status zero to two
- •3. Lung and cardiac function adequate for proposed resection
- •4. pT1 pN1 M0, pT2 pN1 M0, pT1 pN2 M0 or pT2 pN2 M0 non-small cell lung cancer
- •5. Complete resection of non-small cell lung cancer
排除标准
- •1. Previous specific anti-cancer treatment for current disease
- •2. Presence of other malignant disease, except basal cell carcinoma or in situ carcinoma of the cervix
- •3. Presence of other serious condition contraindicating surgery or radiotherapy
研究者
相似试验
已完成
不适用
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional FractionationNon-Small Cell Lung CancerNCT02189967Technische Universität Dresden38
已完成
4 期
Effectiveness of postoperative radiotherapy in patients with oral or oropharyngeal squamous cell carcinoma and histologically confirmed single ipsilateral lymphnode metastasis (pN1)head-neck cancer metastasis1002747610019190oral cancerNL-OMON30589Academisch Medisch Centrum12
已完成
不适用
Post-Operative Radiotherapy for Selected High Risk Rectal AdenocarcinomaColorectal cancerColorectalCancerISRCTN91411631orthern and Yorkshire Clinical Trials and Research Unit (UK)
已完成
不适用
Post-operative Radiotherapy In Minimum-risk Elderly - Phase IIBreastBreast cancerCancerISRCTN95889329niversity of Edinburgh (UK)1,326
招募中
3 期
Postoperative radiotherapy (PORT) for pathological N2 non-small cell lung cancer with adjuvant chemotherapy: a randomized phase III trial (JCOG1916, J-PORT)pathological N2 non-small cell lung cancerJPRN-UMIN000042905Japan Clinical Oncology Group (JCOG)330